DYRK1A and DYRK1B play key roles in neurodevelopment and cancer biology and are increasingly recognized as potential drug targets in disorders including Alzheimer’s disease, diabetes mellitus, metabolic syndrome, heart disease, and cancer18–22. Here, DYRK1A is linked to cancer.